SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 4, 2013

 

CAPLEASE, INC.

(Exact name of registrant as specified in its charter)

 

Maryland   1-32039   52-2414533
         
(State or other jurisdiction   (Commission   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)

 

1065 Avenue of the Americas, New York, NY   10018
     
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:      (212) 217-6300

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 1.01Entry into a Material Definitive Agreement.

 

On April 4, 2013, CapLease, Inc. (the “Company”) entered into an underwriting agreement with Wells Fargo Securities, LLC, as representative of the several underwriters named in the underwriting agreement. Pursuant to the terms and conditions of the underwriting agreement, the Company agreed to sell 7,500,000 shares of common stock (the “Initial Shares”) to the underwriters, and granted the underwriters an option exercisable for 30 days to purchase up to an additional 1,125,000 shares of common stock (the “Option Shares”) to cover over-allotments of shares. The underwriters agreed to pay the Company a purchase price per share of $5.70135 (reflecting a price to the public of $5.97 per share, less an underwriting discount of $0.26865 per share). The underwriting agreement contained customary representations and warranties, indemnification provisions and closing conditions. The foregoing description of the underwriting agreement is qualified in its entirety by reference to the underwriting agreement filed as Exhibit 1 to this Form 8-K and incorporated herein by reference. Legal opinions delivered regarding the legality of the shares of common stock offered and certain tax matters are attached as Exhibits 5 and 8, respectively, to this Form 8-K.

 

The underwriters have exercised the over-allotment option in full, and the issuance and sale of the Initial Shares and the Option Shares closed on April 9, 2013.

 

The common stock was offered pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-171408), which was declared effective on February 14, 2011 by the Securities and Exchange Commission.

 

 
 

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits

 

  Exhibit   Description
       
  1   Underwriting Agreement, dated April 4, 2013, by and between the Company and Wells Fargo Securities, LLC, as representative of the several underwriters.
       
  5   Opinion of Hunton & Williams LLP regarding legality.
       
  8   Opinion of Hunton & Williams LLP regarding tax matters.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CAPLEASE, INC.
   
  By: /s/ Paul C. Hughes
  Paul C. Hughes
 

Vice President, General Counsel

  and Corporate Secretary

 

DATE: April 9, 2013